Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Revenue (2020 - 2025)

LifeStance Health (LFST) has disclosed Revenue for 6 consecutive years, with $382.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 17.43% to $382.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 billion, a 13.85% increase, with the full-year FY2025 number at $1.4 billion, up 13.85% from a year prior.
  • Revenue was $382.2 million for Q4 2025 at LifeStance Health, up from $363.8 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $382.2 million in Q4 2025 to a low of $143.1 million in Q1 2021.
  • A 5-year average of $272.2 million and a median of $271.7 million in 2023 define the central range for Revenue.
  • Peak YoY movement for Revenue: skyrocketed 253.22% in 2021, then crashed 39.15% in 2022.
  • LifeStance Health's Revenue stood at $376.9 million in 2021, then tumbled by 39.15% to $229.4 million in 2022, then grew by 22.34% to $280.6 million in 2023, then grew by 15.99% to $325.5 million in 2024, then grew by 17.43% to $382.2 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Revenue are $382.2 million (Q4 2025), $363.8 million (Q3 2025), and $345.3 million (Q2 2025).